Emergent Biosolutions reported $1.52B in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 566.96M 2.12M
Akebia Therapeutics AKBA:US $ 137.15M 37.48M
ALKERMES ALKS:US $ 1096.17M 1.73M
Alnylam Pharmaceuticals ALNY:US $ 755.89M 97.47M
Amarin AMRN:US $ 642.5M 2.83M
Ani Pharmaceuticals ANIP:US $ 191.4M 0.51M
Biomarin Pharmaceutical BMRN:US $ 4266.15M 24.58M
Chimerix CMRX:US $ 104.59M 14.56M
Coherus Biosciences CHRS:US $ 130.76M 25.46M
Emergent Biosolutions EBS:US $ 1522.7M 21M
Exact Sciences EXAS:US $ 3457.59M 101.51M
Exelixis EXEL:US $ 2112.45M 69.37M
Flexion Therapeutics FLXN:US $ -82377000 26.21M
Glaxosmithkline GSK:US $ 15426M 49M
Heron Therapeutics HRTX:US $ 118.84M 41.27M
Immunogen IMGN:US $ 77.09M 8.63M
Intercept Pharmaceuticals ICPT:US $ -156.03M 47.16M
Ironwood Pharmaceuticals IRWD:US $ 579.94M 68.18M
JAZZ PHA JAZZ:US $ 3938.48M 193.01M
Lexicon Pharmaceuticals LXRX:US $ 136.6M 630K
Lonza Group LONN:SW 7.27B 452M
Moderna Inc MRNA:US 10.12B 3.42B
Myriad Genetics MYGN:US $ 968.6M 66.1M
Nektar Therapeutics NKTR:US $ 801.54M 103.44M
Neurocrine Biosciences NBIX:US $ 1346M 66.8M
Opko Health OPK:US $ 1765.57M 22.98M
Pacira Pharmaceuticals PCRX:US $ 718.6M 31.43M
Ptc Therapeutics PTCT:US $ 104.93M 91.65M
Sarepta Therapeutics SRPT:US $ 469.53M 15.58M
Seattle Genetics SGEN:US $ 3164.96M 226.32M
Teva Pharmaceutical Industries TEVA:US $ 10467M 143M
United Therapeutics UTHR:US $ 3829.7M 190.2M
Vanda Pharmaceuticals VNDA:US $ 493.32M 12.1M
Xoma XOMA:US $ 111.58M 4.99M